Senior Gross To Net Forecasting & Innovation Manager

About the Department The Finance & Operations department brings insights and intelligence to inform decision making & drives digitalization and business solutions to attain NNI goals. Finance & Operations works closely across the organization to guide enterprise-wide resource allocations, investment choices, drive core operations and develop insights to drive growth and operational excellence across the value chain while innovating for future capabilities. Our focus on innovation ensures we're constantly building future capabilities. We're responsible for regulating accounting, upholding workplace safety, managing our supply chain and sampling, supporting technological and data innovation, maintaining our facilities and assuring the integrity and completeness of all business transactions. At Novo Nordisk, you will have the opportunity to build a career in a global business environment. We encourage our employees to make the most of their talent, and we reward hard work and dedication with opportunities for continuous learning and personal development. Are you ready to maximize your potential with us? The Position The position is responsible for gross-to-net forecasting for the US business, ensuring external and internal customer alignment as necessary. The role leads support for development of gross-to-net forecasts for various brands within the NNI portfolio, demonstrates strong gross-to-net knowledge to support financial assessments across the organization, and provides support for "special / innovative" forecasting projects, including process improvements, next-generation platforms, current generation model enhancements, and creation/implementation of Business Intelligence platforms. As an internal consultant, the individual collaborates with Finance, Pricing & Contracting, Commercial and Strategy teams. The position is responsible for the gross-to-net forecasting process and tools, including ensuring all models are up-to-date with the latest methodologies and insights. Based on assessment of market trends and expected future events, this individual is responsible for helping support delivery of holistic, insight-driven gross-to-net forecasts for various rebate categories for current and future Novo Nordisk products. The role efficiently and accurately forecasts gross-to-net components including but not limited to Managed Care, Medicare Part D, Medicaid, and current and future Healthcare Reform related deductions as well as other rebates and deductions. Communication of realistic expectations is conducted in a clear, concise, transparent manner to all levels of the organization. The individual sets direction and drives continuous improvement of forecasting methodologies, tools, and core deliverables. Relationships Reports to the Director, GTN Forecasting. The position regularly interacts with members in PCOR, Strategy & Innovation, Supply Chain, Accounting, PSP, HQ Corporate Finance and some teams within Commercial Insights & Analytics, and maintains external relationships with vendors. Essential Functions Participate and help drive GTN understanding and price implications of certain strategies (together with S&I and PCOR) to support GTN forecast of future product launches. Develop an understanding of current products with specific segments and assist with GTN forecasting for those products to support AB/RE budget processes. Oversee and comment on all key gross-to-net inputs into the net sales forecast, including but not limited to Rebate Forecast pricing and contracting event input provided by PCOR, strategic inputs on launch brands from S&I, and affinity inputs from PSP. Collaborate with Strategy and Innovation (S&I) and PCOR on any GTN related items. Develop and communicate the NNI AB (Anchor Budget) and RE (Rolling Estimate) forecasts. Develop ad hoc analysis tools to support forecasting. Business Intelligence (BI) and Process Efficiencies. Use BI tools and visualizations to improve current gross-to-net processes and enhance transparency. Assess current and new forecasting tools, models, and approaches that inform the GTN outlook for Novo Nordisk brands; identify and introduce process efficiencies. Assess current data sets and data models to identify and introduce better GTN transparency and analytics. Work closely with Global Business Services (GBS), HQ BI COE, and Finance Digitalization team to build/enhance BI capabilities across the gross-to-net forecasting and sales reporting functions. Ad Hoc Projects/Analyses: Executes delegated ad hoc projects independently, ensuring such projects are completed on schedule, within budget, per direction, and are internally consistent with group deliverable quality. Systems and Data Management: Responsible for gross-to-net forecast models, tools and overall process. Proposes recommendations for enhancements and/or improvements based on industry trends and evolving business needs. Continuously reviews and evaluates the quality of data and new data sources used in analyses, generating new insights. Controls, Compliance and Finance: Responsible for ensuring that all rebate controls meet all audit and internal control (Sarbox) requirements. Physical Requirements 0–10% overnight travel required. Qualifications Education Level – Bachelor’s degree from an accredited institution required. Degree in an analytical field (e.g., economics, business, finance, engineering, econometrics, or statistics) is preferred. Master’s degree in an analytical field (and/or MBA and/or CPA) preferred. Experience Level – Minimum of 6 years of relevant experience demonstrating a steady career progression with increasing roles of responsibility; minimum of 4 years of relevant analytics, Gross-to-Net (GTN) forecasting‑related experience. Gross-to-net forecasting-related experience from the pharmaceutical industry strongly desired. Specific or Technical Job Skills – Strong collaboration skills required, with experience implementing a new system across a large, cross‑functional team preferred. Ability to plan, prioritize and follow through in a timely manner and anticipate potential roadblocks. Strong understanding of gross-to-net components, with experience in forecasting key rebate categories including Commercial, Medicare Part D, Coverage Gap, and Medicaid. Demonstrated analytical skills via MS Excel and presentation/communication skills via MS PowerPoint required. Prior Business Intelligence (BI) and data visualization experience strongly preferred (Tableau, Qlik, Power BI, Alteryx, etc.). Ability to effectively communicate insights to senior management teams, synthesize complex information, and make it relevant, understandable, and actionable for internal stakeholders required. Strong analytical, problem‑solving, and quantitative analysis skills required. Strong innovation and adaptability: must identify better ways of doing things and work with others to improve methods and procedures; required. The base compensation range for this position is $120,300 to $222,600. Base compensation is determined based on a number of factors. This position is also eligible for a company bonus based on individual and company performance. Novo Nordisk offers long‑term incentive compensation and/or company vehicles depending on the position’s level or other company factors. Employees are also eligible to participate in company employee benefit programs including medical, dental and vision coverage; life insurance; disability insurance; 401(k) savings plan; flexible spending accounts; employee assistance program; tuition reimbursement program; and voluntary benefits such as group legal, critical illness, identity theft protection, pet insurance and auto/home insurance. The company also offers time off pursuant to its sick time policy, flexible vacation policy, and parental leave policy. We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. Novo Nordisk is an equal opportunity employer. Qualified applicants will receive consideration for employment without regard to race, ethnicity, color, religion, sex, gender identity, sexual orientation, national origin, disability, protected veteran status or any other characteristic protected by local, state or federal laws, rules or regulations. #J-18808-Ljbffr Initial Therapeutics, Inc.